This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Singh, P. K. Articles by Hollingsworth, M. A. Search for Related Content PubMed PubMed Citation Articles by Singh, P. K. Articles by Hollingsworth, M. A.

Platelet-Derived Growth Factor Receptor ß–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells

¹ Eppley Institute for Research in Cancer and Allied Diseases and ² Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska; ³ Department of Biochemistry/Molecular Biology Program, Mayo Clinic College of Medicine, Scottsdale, Arizona; ⁴ Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; and ⁵ University of Nebraska-Lincoln, Lincoln, Nebraska

Requests for reprints: Michael A. Hollingsworth, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805. Phone: 402-559-8343; Fax: 402-559-3339; E-mail: mahollin{at}unmc.edu.

MUC1 is a heterodimeric transmembrane glycoprotein that is overexpressed and aberrantly glycosylated in ductal adenocarcinomas. Differential phosphorylation of the MUC1 cytoplasmic tail (MUC1CT) has been associated with signaling events that influence the proliferation and metastasis of cancer cells. We identified a novel tyrosine phosphorylation site (HGRYVPP) in the MUC1CT by mass spectrometric analysis of MUC1 from human pancreatic adenocarcinoma cell lines. Analyses in vitro and in vivo showed that platelet-derived growth factor receptor ß (PDGFRß) catalyzed phosphorylation of this site and of tyrosine in the RDTYHPM site. Stimulation of S2-013.MUC1F cells with PDGF-BB increased nuclear colocalization of MUC1CT and ß-catenin. PDGF-BB stimulation had no significant effect on cell proliferation rate; however, it enhanced invasion in vitro through Matrigel and in vivo tumor growth and metastases. Invasive properties of the cells were significantly altered on expression of phosphorylation-abrogating or phosphorylation-mimicking mutations at these sites. We propose that interactions of MUC1 and PDGFRß induce signal transduction events that influence the metastatic properties of pancreatic adenocarcinoma. [Cancer Res 2007;67(11):5201–10]

This article has been cited by other articles:

				P. K. Singh, M. E. Behrens, J. P. Eggers, R. L. Cerny, J. M. Bailey, K. Shanmugam, S. J. Gendler, E. P. Bennett, and M. A. Hollingsworth Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression J. Biol. Chem., October 3, 2008; 283(40): 26985 - 26995. [Abstract] [Full Text] [PDF]

				Y. Nakamura, F. Tanaka, Y. Yoshikawa, K. Mimori, H. Inoue, K. Yanaga, and M. Mori PDGF-BB is a Novel Prognostic Factor in Colorectal Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2129 - 2136. [Abstract] [Full Text] [PDF]

				M.-K. Shyu, M.-C. Lin, C.-H. Liu, Y.-R. Fu, J.-C. Shih, C.-N. Lee, H.-Y. Chen, J. Huang, M.-C. Huang, and F.-J. Hsieh MUC1 Expression Is Increased During Human Placental Development and Suppresses Trophoblast-Like Cell Invasion In Vitro Biol Reprod, August 1, 2008; 79(2): 233 - 239. [Abstract] [Full Text] [PDF]

				D. D. Carson The Cytoplasmic Tail of MUC1: A Very Busy Place Sci. Signal., July 8, 2008; 1(27): pe35 - pe35. [Abstract] [Full Text] [PDF]

				Q. Shen, J. J. Rahn, J. Zhang, N. Gunasekera, X. Sun, A. R.E. Shaw, M. J. Hendzel, P. Hoffman, A. Bernier, and J. C. Hugh MUC1 Initiates Src-CrkL-Rac1/Cdc42-Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1 Mol. Cancer Res., April 1, 2008; 6(4): 555 - 567. [Abstract] [Full Text] [PDF]

				Z. Wang, D. Kong, S. Banerjee, Y. Li, N. V. Adsay, J. Abbruzzese, and F. H. Sarkar Down-regulation of Platelet-Derived Growth Factor-D Inhibits Cell Growth and Angiogenesis through Inactivation of Notch-1 and Nuclear Factor-{kappa}B Signaling Cancer Res., December 1, 2007; 67(23): 11377 - 11385. [Abstract] [Full Text] [PDF]